Condition
Pancreas Cancer, Metastatic
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (3)
P 2 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07457541Phase 1Active Not Recruiting
Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI
NCT04907643Not ApplicableRecruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NCT04150042Phase 1Recruiting
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT07341737Phase 1Not Yet Recruiting
SL-28 for Advanced Solid Tumours
NCT04835402Phase 2UnknownPrimary
Electroporation Potentiated Immunotherapy in Cancer
Showing all 5 trials